Edges in Network
| Network | GSE7696_egf1520 - GSE7696 - SiGN-BN HC+Bootstrap |
| Network Description | Glioblastoma from a homogenous cohort of patients treated within clinical trial |
| Node | ARSJ |
| Upstream (Parents) |
|---|
| (<<) ADAM19 → ARSJ |
| (<<) DUSP6 → ARSJ |
| (<<) EMP1 → ARSJ |
| (<<) GNG5 → ARSJ |
| (<<) ITGA7 → ARSJ |
| (<<) LGALS3 → ARSJ |
| (<<) MAPK8 → ARSJ |
| (<<) MAPK9 → ARSJ |
| (<<) MYO1E → ARSJ |
| (<<) PKIA → ARSJ |
| (<<) PPP1R3B → ARSJ |
| (<<) RFFL → ARSJ |
| (<<) THRA → ARSJ |
| (<<) VAV3 → ARSJ |
| (<<) VEGFA → ARSJ |
| Downstream (Children) |
|---|
| ARSJ → ADORA2B (>>) |
| ARSJ → CAPRIN2 (>>) |
| ARSJ → CD274 (>>) |
| ARSJ → CHI3L1 (>>) |
| ARSJ → CHST2 (>>) |
| ARSJ → DUSP4 (>>) |
| ARSJ → FZD7 (>>) |
| ARSJ → HOPX (>>) |
| ARSJ → IGFBP7 (>>) |
| ARSJ → MAP2K3 (>>) |
| ARSJ → MREG (>>) |
| ARSJ → PKIB (>>) |
| ARSJ → PLOD2 (>>) |
| ARSJ → SOCS2 (>>) |
| ARSJ → SPRY2 (>>) |
| ARSJ → SPRY4 (>>) |
| ARSJ → TMEM154 (>>) |
